Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 130+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.


Covid-19 Announcement

IDIFARMA is fully committed to the well-being of our employees, the quality of the services we provide to our valuable clients and our contribution to the general health of all people.


Idifarma will attend the following events during 2020 Would you like to meet us? Contact us at to schedule a meeting!


In order to ensure the business continuity of the company activities in this challenging health crisis, Idifarma have implemented important safety measures.

You can find them in the following link

We are all in this together, and together we will prevail

Our Business Development Director, Manuel Leal , will participate in the event Pharma Contract Manufacturing (17-18 March, Munich).
If you want to arrange a meeting there, contact us at!

The industrial division of SUANFARMA, as a specialized CDMO, offers our customers a “One Stop Shop” service to succeed in the challenge of developing, scaling and manufacturing an innovative or generic API, and the support offered in the FDF activity.

Idifarma, together with other important companies as Catalent, Evonik or BASF, has participated in an interesting article in Drug Development & Delivery magazine regarding the technologies applied in order to improve the solubility of drugs.

Read all,

Nucaps has carried out a new capital increase thanks to clave, which joins our Management Board, next to @CNTA_CIT, @unav and @Idifarma

Thank you!

#nucaps #nucapsnanotechnology #nanotechnology #nanotecnologia #nanoencapsulation #clave #innovation #innovacion #startup

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies